XLerateHealth focuses on early-stage healthcare startups, particularly in the Midwest and Southeast regions of the United States. They primarily engage in pre-seed and seed investment rounds, offering a nationally recognized 12-week accelerator program to help startups increase their chances of success. The firm's goal is to support impactful healthcare innovation that might otherwise go unrecognized and underfunded.
Notable portfolio companies include Amplified Sciences, Apellis Pharmaceuticals, and RxLightning. XLerateHealth connects startups with clinical, academic, and business leaders to provide comprehensive guidance. Key partners and mentors bring a wealth of expertise from various sectors, enhancing the firm's ability to offer unique value-add services such as strategic advice and industry connections.
XLerateHealth - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments29
Current Portfolio Count27
Total Portfolio Exits1
Top Investment Stages
Pre-Seed19 (65.5%)
Seed8 (27.6%)
Convertible Note1 (3.4%)
Non Equity Assistance1 (3.4%)
Stage Mix
Pre-Seed 66%Seed 28%Convertible Note 3%Non Equity Assistance 3%
Concentration shown as share of disclosed investments by stage.
XLerateHealth - Classification
- Also Known As
- Xleratehealth, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 7300Business Services
Show 2 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541000Professional, Scientific, and Technical Services